JIGAR SIRROZINI ERTA BOSQICHDA ANIQLASHDA ULTRATOVUSH TEKSHIRUVINING DIAGNOSTIK IMKONIYATLARI
Keywords:
Kalit so'zlar: jigar sirrozi, ultratovush tekshiruvi (UTT), erta diagnostika, fibroz darajasi, elastografiya, portal gipertenziya, Doppler ultratovush, jigar to'qimasi, invaziv bo'lmagan usullar, surunkali jigar kasalliklari.Abstract
Annotatsiya: Jigar sirrozi zamonaviy tibbiyotning dolzarb muammolaridan biri bo'lib, kasallik ko'pincha belgilarsiz rivojlanib, kech bosqichda aniqlanadi. Ushbu ilmiy ishda 25–60 yoshdagi jigar kasalligi xavf guruhiga mansub 120 nafar bemorda ultratovush tekshiruvi (UTT)ning erta diagnostikadagi samaradorligi o'rganildi. Tadqiqot 3 yil davomida prospektiv kuzatuv shaklida olib borildi. Har bir bemorga B-rejimli UTT, dopplerografiya, elastografiya va kontrastli tekshiruv o'tkazildi. Olingan natijalar ALT, AST, bilirubin kabi laboratoriya ko'rsatkichlari bilan taqqoslandi. Tadqiqot shuni isbotladiki, elastografiya va dopplerografiya bilan birgalikda qo'llaniladigan UTT jigar fibrozining dastlabki belgilarini, portal tizim o'zgarishlarini va yashirin kechuvchi sirroz alomatlarini klinik simptomlar paydo bo'lishidan ancha oldin aniqlash imkonini beradi. Bu esa kasallikning oldini olish va davolash natijalari uchun muhim ahamiyat kasb etadi.
References
1. European Association for the Study of the Liver (EASL). Clinical Practice Guidelines on the management of liver cirrhosis. Journal of Hepatology, 2021; 75(3): 523–556.
2. American Association for the Study of Liver Diseases (AASLD). Practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology, 2020; 73(1): 328–371.
3. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis: epidemiology, pathophysiology and management. The Lancet, 2014; 383(9930): 1749–1761.
4. Schuppan D, Afdhal NH. Liver cirrhosis: current approaches to pathogenesis and treatment. Gastroenterology, 2008; 134(7): 1899–1912.
5. European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). Updated Clinical Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, 2023.
6. Lurie Y, Webb M, Cytter-Kuint R, et al. Non-invasive diagnosis of liver fibrosis and cirrhosis. World Journal of Gastroenterology, 2015; 21(41): 11567–11583.
7. Kim BK, Park YN, Kim DY, et al. Applicability of liver stiffness measurement and other non-invasive assessment methods for advanced hepatic fibrosis in patients with chronic hepatitis B. Liver International, 2016; 36(9): 1293–1302.
8. Ferraioli G, Filice C, Castera L, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography, Part 3: Liver. Ultrasound in Medicine and Biology, 2015; 41(5): 1161–1179.
9. Berzigotti A, Seijo S, Reverter E, et al. Assessing portal hypertension in liver diseases. Expert Review of Gastroenterology and Hepatology, 2013; 7(2): 141–155.
10. Cobbold JF, Taylor-Robinson SD. Noninvasive assessment of liver fibrosis and cirrhosis: current and future modalities. Current Gastroenterology Reports, 2009; 11(1): 26–33.
11. de Franchis R, Baveno VII Faculty. Renewing consensus in portal hypertension: Report of the Baveno VII Consensus Workshop. Journal of Hepatology, 2022; 76(4): 959–974.
12. Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology, 2019; 156(5): 1264–1281.
13. Piscaglia F, Salvatore V, Mulazzani L, et al. Ultrasound shear wave elastography for liver disease. A critical appraisal of the many actors on the stage. Ultraschall in der Medizin, 2016; 37(1): 1–5.
14. Barr RG, Ferraioli G, Palmeri ML, et al. Elastography assessment of liver fibrosis: Society of Radiologists in Ultrasound consensus statement. Radiology, 2015; 276(3): 845–861.
15. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine and Biology, 2003; 29(12): 1705–1713.
16. Pellicelli AM, D’Ambrosio C, Barbaro G, et al. Hepatocellular carcinoma and liver cirrhosis: role of ultrasonography in early detection. European Journal of Gastroenterology and Hepatology, 2016; 28(5): 543–549.
17. Gines P, Krag A, Abraldes JG, et al. Liver cirrhosis. The Lancet, 2021; 398(10308): 1359–1376.
18. Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall in der Medizin, 2017; 38(4): e16–e47.
19. Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology, 2008; 47(1): 332–342.
20. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease — meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016; 64(1): 73–84.
